Innovator of the Year Award
Novo Nordisk and Vivtex partner in deal worth up to $2.1bn
The companies aim to develop next-generation oral medicines for obesity and diabetes
Novo Nordisk and Aspect Biosystems expand collaboration on diabetes research
The companies are working together on cellular medicines to boost, replace or repair biological functions
Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa
The company is planning to submit regulatory applications for the candidate by the end of the year
Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn
The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study
Eli Lilly announces $3bn expansion to US injectables manufacturing facility
The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines
Sanofi unveils plans to build €1bn insulin production base in China
The site will focus on serving the insulin medication needs of local diabetic patients
Common antidiabetic drug metformin found to slow growth of precancerous cells
The findings suggest that the drug could be used to manage squamous oesophageal cancer risk
Eli Lilly’s once-weekly insulin candidate shows promise in late-stage diabetes trials
It is hoped that a once-weekly treatment option could improve adherence rates
Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference
Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...
Afon Technology’s glucose monitoring device secures Junkosha award plus $25,000 prize
The company was presented with the award in recognition of its Glucowear device
Researchers identify early treatment strategy for diabetic patients at risk of kidney disease
The chronic disease is currently the leading cause of kidney failure in the UK
Novo Nordisk’s Awiqli receives CHMP recommendation to treat diabetes in adults
The chronic disease is estimated to affect 415 million people worldwide